In the external validation set, significant differences were found in EER (FDR-adjusted p-value = 0.002) and mean minimum ADC values (FDR-adjusted p-value = 0.002) between HER2-low and HER2-zero breast cancers. The gene discussed is ERBB2; the disease is breast carcinoma.